Teva Celebrates Commitment to Neuroscience Research Including ALS

This week Prize4Life’s Scientific Director Dr. Neta Zach was invited to attend the official launch of the National Network of Excellence in Neuroscience (NNE), which is a five year $15 million initiative supported by Teva Pharmaceutical Industries Ltd. The network is set to promote collaboration between Israeli neuroscience researchers, harnessing Israel’s unique neuroscience expertise in order “to increase the potential to translate basic science into therapeutic options.” Importantly, the NNE is committed to supporting and furthering ALS research. So far, the NNE has awarded two research grants and two postdoctoral fellowships to ALS researchers. Prize4Life has been working directly with Teva to support this initiative and was instrumental in encouraging the commitment of NNE resources to ALS. Click here for the full story.

Copyright © 1996–2018 Biomedical Research Forum, LLC. All Rights Reserved.

Share this:
Facebooktwittergoogle_plusmailFacebooktwittergoogle_plusmail